About Us

We are the industry leader of high-quality, US-made, patient-centric medicines. We offer the industry-leading full line of innovative unit-dose and liquid medications, direct contracting and supply, and dedicated customer service support.

Learn More

New Additions

New
SORBITOL SOLUTION 70% USP
New
MORPHINE SULFATE ORAL SOLUTION
New
SENNA SYRUP (8.8 mg SENNOSIDES/5 mL)
New
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL, DEXTROMETHORPHAN HYDROBROMIDE SYRUP
New
ACETAMINOPHEN ORAL SUSPENSION
New
CHILDREN’S ACETAMINOPHEN ORAL SUSPENSION (Grape flavored)

Our Products

With over 250 product NDCs, PAI Pharma offers the broadest portfolio of unit-dose and liquid medicines. Our products are manufactured in an FDA CGMP-compliant facility and supported by a rigorous quality control process.

Explore Our Portfolio

Latest News

Press Release

PAI Further Bolsters its Portfolio with the Acquisition of Teligent Sterile Injectable and Topical Products

Pharmaceutical Associates, Inc. (PAI) announces that it has acquired all of the generic and branded US marketing authorizations from Teligent Inc. (Teligent) for an undisclosed amount. Read More

02/03/2022
Press Release

Pharmaceutical Associates, Inc. Appoints Dr. Suketu Sanghvi as Chief Scientific Officer

Pharmaceutical Associates, Inc. (PAI) announced today the appointment of Dr. Suketu Sanghvi as Chief Scientific Officer. Read More

06/16/2021
Press Release

Pharmaceutical Associates, Inc. Names Business Development Strategist Brandon Rockwell as Chief Operating Officer

Pharmaceutical Associates, Inc. (PAI) today announced the appointment of Brandon Rockwell as Chief Operating Officer. Read More

03/03/2021
View All

Join our Team

As a patient-focused company, our employees are the one that help us make a real difference. Our team is continuously evolving and growing, with opportunities in research and development, sales, marketing, finance, human resources, manufacturing, and technology.

View Openings